A comparative study of fixed-dose, step-down, and low-dose step-up regimens of human menopausal gonadotropin for patients with polycystic ovary syndrome

Fertility and Sterility

Volumn 70, Issue 5, 1998, Pages 840-846

  Andoh, Kazumichi ^a   Mizunuma, Hideki ^a   Liu, Xiaowei ^a   Kamijo, Takanori ^a   Yamada, Kiyohiko ^a   Ibuki, Yoshito ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Human menopausal gonadotropin; Low dose; Ovulation induction; Polycystic ovary syndrome; Step down

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; EMBRYO DEVELOPMENT; FEMALE; HORMONE BLOOD LEVEL; HORMONE RESPONSE; HUMAN; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

ADULT; ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HORMONES; HUMANS; MENOTROPINS; OVARIAN FOLLICLE; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TESTS;

EID: 0032212936     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00308-2     Document Type: Article

References (30)

1. Levene M., Wild J., Steer P. Higher multiple births and the modern management of infertility in Britain. Br J Obstet Gynaecol. 99:1992;607-613.
2. Tuppin P., Blondel B., Kaminski M. Trends in multiple deliveries and infertility treatments in France. Br J Obstet Gynaecol. 100:1993;383-385.
3. Evans M.I., Littmann L., St. Louis L., LeBlanc L., Addis J., Johnson M.P., et al. Evolving patterns of iatrogenic multifetal pregnancy generation implications for aggressiveness of infertility treatments . Am J Obstet Gynecol. 172:1995;1750-1755.
4. Imaizumi Y. Recent and long term trends of multiple birth rates and influencing factors in Japan. Journal of Epidemiology. 4:1994;103-109.
5. Jones H.W. Twin or more. Fertil Steril. 63:1995;701-702.
6. Meldrum D.R. Low-dose follicle-stimulating hormone therapy for polycystic ovarian disease. Fertil Steril. 55:1991;1039-1040.
7. Yen S.S.C. The polycystic ovary syndrome. Clin Endocrinol (Oxf). 12:1980;117-207.
8. Kamrava M.M., Seibel M.M., Berger M.J., Thompson I., Taymor M.L. Reversal of persistent anovulation in polycystic ovarian disease by administration of chronic low-dose follicle-stimulating hormone. Fertil Steril. 37:1982;520-523.
9. Polson D.W., Mason H.D., Kiddy D.S., Winston R.M.L., Margara R., Franks S. Low-dose follicle-stimulating hormone in the treatment of polycystic ovary syndrome a comparison of pulsatile subcutaneous with daily intramuscular therapy . Br J Obstet Gynaecol. 96:1989;746-748.
10. Brown J.B. Pituitary control of ovarian function - concepts derived from gonadotrophin therapy. Aust N Z J Obstet Gynaecol. 18:1978;46-54.
11. Ben-Rafael Z., Levy T., Schoemaker J. Pharmacokinetics of follicle-stimulating hormone clinical significance . Fertil Steril. 63:1995;689-700.
12. Buvat-Herbaut M., Marcolin G., Dehaene J.L., Verbecq P., Renouard O. Purified follicle-stimulating hormone in polycystic ovary syndrome slow administration is safer and more effective . Fertil Steril. 52:1989;553-559.
13. Shoham Z., Patel A., Jacobs H.S. Polycystic ovarian syndrome safety and effectiveness of stepwise and low-dose administration of purified follicle-stimulating hormone . Fertil Steril. 55:1991;1051-1056.
14. Hamilton-Fairley D., Kiddy D., Watson H., Sagle M., Franks S. Low-dose gonadotropin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum Reprod. 6:1991;1095-1099.
15. Strowitzki T., Seehaus D., Korell M., Hepp H. Low-dose follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome. J Reprod Med. 39:1994;499-503.
16. Homburg R., Levy T., Ben-Rafael Z. A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for ovulation induction associated with polycystic ovary syndrome. Fertil Steril. 63:1995;729-733.
17. Grigoriou O., Antoniou G., Antonaki V., Patsouras C., Zioris C., Karakitsos P. Low-dose follicle-stimulating hormone treatment for polycystic ovarian disease. Int J Gynecol Obstet. 52:1996;55-59.
18. Mizunuma H., Takagi T., Yamada K., Andoh K., Ibuki Y., Igarashi M. Ovulation induction by step-down administration of purified urinary follicle-stimulating hormone in patients with polycystic ovarian syndrome. Fertil Steril. 55:1991;1195-1196.
19. Baird D.T. A model for follicular selection and ovulation lessons from superovulation . J Steroid Biochem. 27:1987;15-23.
20. Fauser B.C.J.M., Donderwinkel P., Schoot D.C. The step-down principle in gonadotropin treatment and the role of GnRH analogues. Baillieres Clin Obstet Gynaecol. 7:1993;309-330.
21. van Santbrink E.J.P., Donderwinkel P.F.J., van Dessel T.J.H.M., Fauser B.C.J.M. Gonadotropin induction of ovulation using a step-down dose regimen single-centre clinical experience in 82 patients . Hum Reprod. 10:1995;1048-1053.
22. Laboratory manual for the examination of human semen and semen-cervical mucus interaction. 2nd ed. 1987;3-13 The Press Syndicate of the University of Cambridge, Cambridge.
23. Daya S., Gunby J., Hughes E.G., Collins J.A., Sagle M.A. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles a meta-analysis . Fertil Steril. 64:1995;347-354.
24. Anderson R.E., Cragun J.M., Chang R.J., Stanczyk F.Z., Lobo R.A. A pharmacodynamic comparison of human urinary follicle-stimulating hormone and human menopausal gonadotropin in normal women and polycystic ovarian syndrome. Fertil Steril. 52:1989;216-220.
25. Larsen T., Larsen J.F., Schioler V., Bostofe E., Fielding C. Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in polycystic ovarian syndrome. Fertil Steril. 53:1990;426-431.
26. Homburg R., Eshel A., Kilborn J., Adams J., Jacobs H.S. Combined luteinizing hormone releasing hormone analogue and exogenous gonadotropins for treatment of infertility associated with polycystic ovaries. Hum Reprod. 5:1990;32-35.
27. Sagle M.A., Hamilton-Fairley D., Kiddy D.S., Franks S. A comparative, randomized study of low-dose human menopausal gonadotropin and follicle-stimulating hormone in women with polycystic ovarian syndrome. Fertil Steril. 55:1991;55-60.
28. Aboulghar M.A., Mansour R.T., Serour G.I., Amin Y.M., Sattar M.A., elAttar E. Recombinant follicle-stimulating hormone in the treatment of patients with history of severe ovarian hyperstimulation syndrome. Fertil Steril. 66:1996;757-760.
29. Hamilton-Fairley D., Kiddy D., Watson H., Paterson C., Franks S. Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br J Obstet Gynaecol. 99:1992;128-131.
30. Brzyski R.G., Grow D.R., Sims J.A., Seltman H.J. Increase in androgen:estrogen ratio specifically during low-dose follicle-stimulating hormone therapy for polycystic ovary syndrome. Fertil Steril. 64:1995;693-697.